Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Telecommunications relay service wikipedia , lookup
Lip reading wikipedia , lookup
Hearing loss wikipedia , lookup
Noise-induced hearing loss wikipedia , lookup
Sensorineural hearing loss wikipedia , lookup
Audiology and hearing health professionals in developed and developing countries wikipedia , lookup
Newborn hearing screening in Western Australia Bailey, HD1, Krishnaswamy J2, Coates H2, French N2, Bower C1 1 TVW Telethon Institute for Child Health Research, Perth Western Australia PO Box 855 West Perth 6872 [email protected] 2 King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children, Perth Western Australia. The aim of the Western Australian Newborn Hearing Screening Programme is early detection of bilateral hearing loss in order to offer and commence intervention by the time the baby is six months of age. Universal hearing screening has been introduced in parts of the USA and Europe. Speech and language outcomes of children with bilateral hearing loss who have commenced intervention by six months are better than those children with bilateral hearing loss who commenced intervention later. In 1997 in Western Australia, the median age for the fitting of hearing aids was 25 months. Estimates of the prevalence of congenital bilateral hearing loss range from 1.4- 3 per 1000 live births. Since February 2000 newborn hearing screening has been offered to all babies born at King Edward Memorial Hospital for Women. During 2000, hearing screening has also been introduced to four more large maternity hospitals in Perth. About 47% of all of the births in Western Australia and 60% of metropolitan births occur at these hospitals. Method: All screening is done by specially trained screeners. The screeners obtain a complete list of the previous day(s) deliveries and every live birth is allocated a unique identification number based on the hospital and year of birth. Written parental consent is obtained prior to screening. Where possible, well babies are screened when at least 24 hours of age. The initial screen is done using an ECHOCHECK (ILO OAE screener) which measures transient evoked otoacoustic emissions (TEOAE). If a pass response is not obtained in both ears, an automated auditory brainstem response measurement (AABR) is done prior to discharge using either the SABre (SLE Ltd.) system or Algo 2e (Natus). Babies who are admitted to a special care nursery are screened when at least 34 weeks gestation and fit enough for the screen. For a small number of high risk babies, AABR technology, rather than TEOAE is used for the initial screen. The results of the screening and basic demographic data are entered onto a specially designed database developed in FileMaker Pro. All babies who do not pass in both ears are given appointments for repeat screening in 2-3 weeks. Any baby who does not pass the follow-up screening in both ears is referred for urgent assessment by a paediatric audiologist while any baby who passes in only one ear is referred for assessment at seven months of age. Results: About 5000 babies were eligible for screening in the first eight months of the programme. Ninety-five percent of babies received hearing screening. Reasons for not being screened included discharged prior to screening, transfer to another hospital and parental refusal. Eighty percent of babies were screened using only TEOAE. In the first five months of screening, 94% of screened babies passed hearing screening in both ears. This increased to 98% in the next three months. A small group of babies who required follow-up were lost due to missing multiple appointments or parental refusal. Of those who received follow-up, 96% passed the follow-up screen. A total of ten babies have been referred for diagnostic assessment for either a unilateral (eight babies) or bilateral (two babies) fail. Of the latter, one was confirmed as having bilateral profound hearing loss and the other is awaiting surgical intervention for a conductive hearing loss. Conclusions: Hearing screening has been successfully introduced at five hospitals in the Perth metropolitan area. Challenges in the future include reducing the proportion of babies who miss screening and continuing to increase the proportion of babies who pass the initial screen. Over the next few months, all aspects of the programme will be evaluated and the cost of screening per baby calculated. This will provide information on which to base the proposed expansion to other maternity hospitals in Western Australia.